Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aavogen is a biotech startup that develops gene therapeutics for muscle wasting diseases.
Viora Health is a tech-enabled human centered program that wraps around the care management to engage patients in their own communities
Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients
Remote Therapeutic Monitoring for Mental Health Treatments
NovaSignal is a medical technology company commercializing a robotic cerebral ultrasound system.
Omniose is an early stage biotechnological company.
custom aptamer development services
BetterAge provides a personalized, web-based program to help individuals improve health and well-being.
Satio brings a dried blood spot and whole blood collection to the consumer; simple, painless, and clean using patches.
SpineX is a bioelectric medtech company that develops non-invasive neuromodulation devices.
Resvita Bio develops and manufactures engineered probiotics for use in treatment if skin related diseases including cancer.
Redefining Sample Preparation, Revolutionizing Genomics
Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.
Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.
Lasarrus develops devices for patients with chronic obstructive pulmonary disease.
TruDiagnostic is a biodata research company that offers epigenetic testing and research services.
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
RealSeq Biosciences’ core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction.
Medical Device Research and Development
Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company .
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
Medentum Innovations promotes health equity and transforming healthcare through affordable, high-performance point-of-care devices.
Center for Justice Research is a research center devoted to data-driven solutions for an equitable criminal justice system.
Strykagen manufactures transforming diagnostics and therapeutics for life-threatening rare muscle diseases.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical, Wellness, Pharmaceutical. The firm invests across 28 different industry categories.
Among tracked funding rounds, NovaSignal received $37.0M in a Series C round. National Institutes of Health's total known invested capital is $1.7B.
National Institutes of Health's average investment size is $4.1M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Aavogen, Viora Health, Lactiga, Levl, NovaSignal. These companies were founded in 2020 or later.